KeyMed Biosciences Inc
F:64Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KeyMed Biosciences Inc
F:64Z
|
CN |
|
Anheuser Busch Inbev SA
F:1NBA
|
BE |
|
E
|
EnerSys
F:FDN
|
US |
|
C
|
Cronos Group Inc
F:7CI
|
CA |
|
A
|
Acadia Realty Trust
F:WX1
|
US |
|
G
|
Goldman Sachs BDC Inc
F:GSB
|
US |
|
Douyu International Holdings Ltd
NASDAQ:DOYU
|
CN |
|
B
|
BML Inc
XMUN:BMZ
|
JP |
|
B
|
Blue Label Telecoms Ltd
XMUN:5TP
|
ZA |
|
S
|
Silvercrest Metals Inc
F:S0C
|
CA |
|
Saga Communications Inc
NASDAQ:SGA
|
US |
|
Q
|
Qiagen NV
DUS:QIA
|
NL |
|
V
|
Vodafone Idea Ltd
BSE:532822
|
IN |
Wall St Price Targets
64Z Price Targets Summary
KeyMed Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 64Z is 7.92 EUR with a low forecast of 6.86 EUR and a high forecast of 9.51 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 64Z's stock price target?
Price Target
7.92
EUR
According to Wall Street analysts, the average 1-year price target for 64Z is 7.92 EUR with a low forecast of 6.86 EUR and a high forecast of 9.51 EUR.
What is the Revenue forecast for KeyMed Biosciences Inc?
Projected CAGR
31%
The compound annual growth rate for Revenue over the next 7 years is 31%.
What is the Gross Profit forecast for KeyMed Biosciences Inc?
Projected CAGR
61%
The compound annual growth rate for Gross Profit over the next 3 years is 61%.
